Q2 2017

Filed Aug 9, 2017 · 10-Q · 40 days after period end · 0000877860-17-000065

Q2 2017 · 10-Q

Revenue

$69.84M

+14.1% vs Q2 2016

Net Income

$38.25M

−14.2% vs Q2 2016

EPS Diluted

$0.93

−19.8% vs Q2 2016

Operating Income$38,245,000+105.6%

Operating Cash Flow

Same quarter

Metric	Q2 2017	Q2 2016	Q2 2015	Q2 2014
Revenue	$69.84M	$61.20M	$56.31M	$44.16M
Net Income	$38.25M	$44.60M	$31.18M	$25.29M
EPS Diluted	$0.93	$1.16	$0.83	$0.76

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR